Quick Takeaways
- FMR LLC filed SCHEDULE 13G/A for CYTOKINETICS INC COMMON STOCK (CYTK).
- Disclosed ownership: 11%.
- Date of event: 31 Jul 2025.
FMR LLC - 31 Jul 2025 SCHEDULE 13G/A Report for CYTOKINETICS INC COMMON STOCK (CYTK)
- Filing Manager
- FMR LLC
- Reporting Manager
- FMR LLC
- Security
- CYTOKINETICS INC COMMON STOCK
- Symbol
- CYTK
- Shares outstanding
- 120,198,130 shares
- Disclosed Ownership
- 13,101,596 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Aug 2025, 10:16:27 UTC
- Date of event
- 31 Jul 2025
- Previous filing
- 12 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"FMR LLC disclosed 11% ownership in CYTOKINETICS INC COMMON STOCK (CYTK) on 31 Jul 2025."
What Changed
- Previous schedule filing date: 12 Feb 2025.
- Current filing was accepted on 07 Aug 2025, 10:16.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FMR LLC | 11% | 13,101,596 | 12,747,498 | 0 | Richard Bourgelas | Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* | |
| Abigail P. Johnson | 11% | 13,101,596 | 0 | 0 | Richard Bourgelas | Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of Abigail P. Johnson* |